91 related articles for article (PubMed ID: 20036889)
1. Expression of VEGF, VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix.
Jach R; Dulinska-Litewka J; Laidler P; Szczudrawa A; Kopera A; Szczudlik L; Pawlik M; Zajac K; Mak M; Basta A
Front Biosci (Elite Ed); 2010 Jan; 2(2):411-23. PubMed ID: 20036889
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis.
Van Trappen PO; Steele D; Lowe DG; Baithun S; Beasley N; Thiele W; Weich H; Krishnan J; Shepherd JH; Pepper MS; Jackson DG; Sleeman JP; Jacobs IJ
J Pathol; 2003 Dec; 201(4):544-54. PubMed ID: 14648657
[TBL] [Abstract][Full Text] [Related]
3. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
Hammes LS; Tekmal RR; Naud P; Edelweiss MI; Kirma N; Valente PT; Syrjänen KJ; Cunha-Filho JS
Gynecol Oncol; 2008 Sep; 110(3):445-51. PubMed ID: 18565574
[TBL] [Abstract][Full Text] [Related]
5. Differential Expression of Aquaporins in Cervical Precursor Lesions and Invasive Cervical Cancer.
Shen Q; Lin W; Luo H; Zhao C; Cheng H; Jiang W; Zhu X
Reprod Sci; 2016 Nov; 23(11):1551-1558. PubMed ID: 27140907
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.
Dobbs SP; Hewett PW; Johnson IR; Carmichael J; Murray JC
Br J Cancer; 1997; 76(11):1410-5. PubMed ID: 9400935
[TBL] [Abstract][Full Text] [Related]
8. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
Hwang-Bo J; Park JH; Bae MG; Chung IS
Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression.
López de Cicco R; Watson JC; Bassi DE; Litwin S; Klein-Szanto AJ
Clin Cancer Res; 2004 Jul; 10(13):4480-8. PubMed ID: 15240540
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C, VEGFR-3, and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro.
Shi X; Chen G; Xing H; Weng D; Bai X; Ma D
Oncol Rep; 2007 Jul; 18(1):241-7. PubMed ID: 17549374
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
14. CD44v3 and VEGF-C expression and its relationship with lymph node metastasis in squamous cell carcinomas of the uterine cervix.
Liu YQ; Li HF; Han JJ; Tang QL; Sun Q; Huang ZQ; Li HG
Asian Pac J Cancer Prev; 2014; 15(12):5049-53. PubMed ID: 24998585
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
17. [Relationships of human laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3].
Wang Z; Li R; Zhou B; Liang W; Liang C; Zhang L; Chen Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):842-6. PubMed ID: 19813623
[TBL] [Abstract][Full Text] [Related]
18. Implications of adrenomedullin expression in the invasion of squamous cell carcinoma of the uterine cervix.
Li Z; Takeuchi S; Otani T; Maruo T
Int J Clin Oncol; 2001 Dec; 6(6):263-70. PubMed ID: 11828944
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of receptor-binding cancer antigen expressed on SiSo cells, vascular endothelial growth factor, and matrix metalloproteinase-9 in cervical carcinoma and correlation thereof with the invasion and metastasis of the cancerous tissues].
Liu R; Pu DM; Cheng YX; Yin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(19):1326-9. PubMed ID: 17727777
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
